About Curt Herberts
Curt Herberts is an executive officer at Kriya Therapeutics.
Curt Herberts reports to the SEC as an officer of 2 public companies: Senti Biosciences (SNTI) and Sangamo Therapeutics (SGMO).
Curt Herberts first appears on SEC filings in 2016.
Experience
This experience comes from SEC filings. The years are when the filings name Curt Herberts in the role, so the role may have started earlier or lasted longer.
SI
Senti Biosciences, Inc.
Chief Operating Officer
2022 · Public company (SNTI)
SI
Sangamo Therapeutics, Inc.
Sr.VP & Chief Business Officer
2016 – 2018 · Public company (SGMO)
Key Colleagues at Startups
The people Curt Herberts works with at each company, as listed on that company's latest Form D.
Kriya Therapeutics, Inc. · Form D/A, Sep 10, 2025
NV
Neelaksh Varshney
Director
MS
Michele Stone
Executive officer
IO
Ilan Oren
Director
SR
Saira Ramasastry
Director
RG
Ryan Gallagher
Director
KM
Keith Manchester
Director
KE
Katherine Eade
Executive officer
JM
James Momtazee
Director
AR
Akshay Rai
Director
SR
Shankar Ramaswamy
Chief Executive Officer and director
BP
Britt Petty
Executive officer
RJ
Roger Jeffs
Director
BF
Brian Furmanski
Executive officer
TG
Trit Garg
Director